Axonics
$68.48
24H
Market Cap
Volume
Supply
Price Chart
About Axonics - AXNX
Axonics, Inc. is a medical technology company that specializes in developing and commercializing novel implantable Sacral Neuromodulation (SNM) devices for patients with urinary and bowel dysfunction. Their innovations are typically geared toward providing minimally invasive solutions intended to improve the quality of life for those suffering from incontinence and overactive bladder conditions.
What are Axonics's core values and mission statement?
Axonics, Inc.'s mission is to improve the lives of patients suffering from urinary and bowel dysfunction by providing advanced and innovative medical devices. Their core values emphasize innovation, patient-centric solutions, integrity, and excellence in their pursuit of bettering patient outcomes and quality of care.
Who founded Axonics and when?
Axonics, Inc. was founded by Raymond W. Cohen and Danny de Roulet in 2012.
Who leads Axonics?
Axonics, Inc. is led by Raymond W. Cohen, who serves as the Chief Executive Officer.
Where is Axonics located, and what is its base country?
Axonics, Inc. is headquartered in Irvine, California, United States.
On which exchanges is Axonics traded?
Axonics, Inc. is traded on the Nasdaq stock exchange under the ticker symbol AXNX.
Historical data
Axonics (AXNX) Price Live Data
The live price of Axonics (AXNX) is $68.48, with a trading volume of 440,658 in the last 24 hours. Wrapstocks updates the AXNX price in real-time. Axonics is up 0.42% in the last 24 hours. The company has a live market cap of $3,493,491,712.00 and a supply of 51,018,499 AXNX stocks.
Axonics (AXNX) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 11 hours and 48 minutes.
